Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Dec 15, 2020; 12(12): 1381-1393
Published online Dec 15, 2020. doi: 10.4251/wjgo.v12.i12.1381
Published online Dec 15, 2020. doi: 10.4251/wjgo.v12.i12.1381
Variable | Person-years at risk in study cohort | Person-years at risk in control cohort | No. of observed cases of cholangiocarcinoma in study cohort | No. of observed cases of cholangiocarcinoma in control cohort | Incidence rate/1000 person-years (95%CI) in study cohort | Incidence rate/1000 person-years (95%CI) in control cohort | P value |
ES/EPBD | |||||||
Total | 1659.70 | 25360.07 | 12 | 7 | 7.23 (3.92-12.29) | 0.28 (0.12-0.55) | < 0.001 |
Gender | |||||||
Male | 889.95 | 13822.88 | 4 | 3 | 4.50 (1.43-10.84) | 0.22 (0.06-0.59) | < 0.001 |
Female | 769.76 | 11537.20 | 8 | 4 | 10.39 (4.83-19.74) | 0.35 (0.11-0.84) | < 0.001 |
Age, years | |||||||
18-49 | 253.84 | 4392.03 | 1 | 0 | 3.94 (0.20-19.43) | 0.00 (0.00-0.00) | < 0.001 |
50-69 | 574.78 | 8631.76 | 4 | 5 | 6.96 (2.21-16.79) | 0.58 (0.21-1.28) | < 0.001 |
> 70 | 831.08 | 12336.28 | 7 | 2 | 8.42 (3.68-16.66) | 0.16 (0.03-0.54) | < 0.001 |
ES/EPBD and CCY | |||||||
Total | 393.11 | 25360.07 | 1 | 7 | 2.54 (0.13-12.55) | 0.28 (0.12-0.55) | 0.011 |
Gender | |||||||
Male | 184.36 | 13822.88 | 0 | 3 | 0.00 (0.00-0.00) | 0.22 (0.06-0.59) | 0.842 |
Female | 208.75 | 11537.20 | 1 | 4 | 4.79 (0.24-23.63) | 0.35 (0.11-0.84) | 0.002 |
Age, yr | |||||||
18-49 | 113.01 | 4392.03 | 0 | 0 | 0.00 (0.00-0.00) | 0.00 (0.00-0.00) | NA |
50-69 | 143.37 | 8631.76 | 1 | 5 | 6.98 (0.35-34.40) | 0.58 (0.21-1.28) | 0.004 |
> 70 | 136.73 | 12336.28 | 0 | 2 | 0.00 (0.00-0.00) | 0.16 (0.03-0.54) | 0.882 |
Without intervention | |||||||
Total | 4364.45 | 25360.07 | 11 | 7 | 2.52 (1.35-4.38) | 0.28 (0.12-0.55) | < 0.001 |
Gender | |||||||
Male | 2345.22 | 13822.88 | 6 | 3 | 2.56 (1.04-5.32) | 0.22 (0.06-0.59) | < 0.001 |
Female | 2019.23 | 11537.20 | 5 | 4 | 2.48 (0.91-5.49) | 0.35 (0.11-0.84) | < 0.001 |
Age, yr | |||||||
18-49 | 871.87 | 4392.03 | 0 | 0 | 0.00 (0.00-0.00) | 0.00 (0.00-0.00) | NA |
50-69 | 1528.74 | 8631.76 | 6 | 5 | 3.93 (1.601-8.16) | 0.58 (0.21-1.28) | < 0.001 |
> 70 | 1963.84 | 12336.28 | 5 | 2 | 2.55 (0.93-5.64) | 0.16 (0.03-0.54) | < 0.001 |
- Citation: Wang CC, Tseng MH, Wu SW, Yang TW, Chen HY, Sung WW, Su CC, Wang YT, Lin CC, Tsai MC. Cholecystectomy reduces subsequent cholangiocarcinoma risk in choledocholithiasis patients undergoing endoscopic intervention. World J Gastrointest Oncol 2020; 12(12): 1381-1393
- URL: https://www.wjgnet.com/1948-5204/full/v12/i12/1381.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i12.1381